Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Gro Egholm, Karsten Tange Veien et al.|New England Journal of Medicine|2025Cited by 73
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rosselló, John Munkhaugen, Arnhild Bakken et al.|The Lancet|2025Cited by 63
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Borja Ibáñez, Arnhild Bakken et al.|New England Journal of Medicine|2025Cited by 39
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, Dan Atar, Eva Prescott et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2023Cited by 21